Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$7.22 USD
+0.16 (2.27%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $7.22 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Nu Skin Enterprises, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 268 | 279 | 355 | 424 | 344 |
Receivables | 73 | 47 | 41 | 63 | 50 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 280 | 346 | 400 | 314 | 276 |
Other Current Assets | 81 | 88 | 77 | 102 | 70 |
Total Current Assets | 702 | 760 | 873 | 903 | 740 |
Net Property & Equipment | 433 | 445 | 454 | 468 | 454 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 336 | 273 | 283 | 293 | 277 |
Deposits & Other Assets | 245 | 244 | 175 | 138 | 154 |
Total Assets | 1,806 | 1,821 | 1,906 | 1,957 | 1,769 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 44 | 54 | 50 | 66 | 39 |
Current Portion Long-Term Debt | 25 | 25 | 108 | 30 | 28 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 260 | 280 | 372 | 447 | 290 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 329 | 359 | 530 | 543 | 357 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 478 | 377 | 269 | 305 | 334 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 107 | 110 | 106 | 102 | 97 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 985 | 924 | 994 | 1,063 | 894 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 622 | 613 | 602 | 580 | 558 |
Retained Earnings | 1,870 | 1,940 | 1,912 | 1,841 | 1,728 |
Other Equity | -100 | -87 | -74 | -65 | -85 |
Treasury Stock | 1,570 | 1,569 | 1,527 | 1,462 | 1,325 |
Total Shareholder's Equity | 822 | 897 | 913 | 894 | 875 |
Total Liabilities & Shareholder's Equity | 1,806 | 1,821 | 1,906 | 1,957 | 1,769 |
Total Common Equity | 822 | 897 | 913 | 894 | 875 |
Shares Outstanding | 49.50 | 49.50 | 49.90 | 50.90 | 55.60 |
Book Value Per Share | 16.61 | 18.13 | 18.29 | 17.57 | 15.74 |
Fiscal Year End for Nu Skin Enterprises, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 233 | 221 | 268 | 250 | 252 |
Receivables | 72 | 67 | 73 | 77 | 67 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 244 | 265 | 280 | 291 | 372 |
Other Current Assets | 106 | 94 | 81 | 83 | 101 |
Total Current Assets | 654 | 647 | 702 | 701 | 793 |
Net Property & Equipment | 412 | 423 | 433 | 429 | 430 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 188 | 333 | 336 | 338 | 342 |
Deposits & Other Assets | 243 | 246 | 245 | 238 | 234 |
Total Assets | 1,586 | 1,742 | 1,806 | 1,793 | 1,894 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 36 | 32 | 44 | 49 | 50 |
Current Portion Long-Term Debt | 30 | 30 | 25 | 140 | 140 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 242 | 247 | 260 | 245 | 256 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 309 | 309 | 329 | 434 | 445 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 428 | 453 | 478 | 363 | 368 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 93 | 107 | 106 | 111 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 900 | 932 | 985 | 971 | 998 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 621 | 619 | 622 | 619 | 616 |
Retained Earnings | 1,746 | 1,867 | 1,870 | 1,882 | 1,939 |
Other Equity | -117 | -111 | -100 | -109 | -101 |
Treasury Stock | 1,564 | 1,565 | 1,570 | 1,571 | 1,558 |
Total Shareholder's Equity | 686 | 810 | 822 | 822 | 895 |
Total Liabilities & Shareholder's Equity | 1,586 | 1,742 | 1,806 | 1,793 | 1,894 |
Total Common Equity | 686 | 810 | 822 | 822 | 895 |
Shares Outstanding | 49.70 | 49.70 | 49.50 | 49.40 | 50.00 |
Book Value Per Share | 13.81 | 16.30 | 16.61 | 16.64 | 17.91 |